688289.SH上海证券交易所 · 科创板 STAR
Sansure Biotech 圣湘生物
Medical Devices 医疗器械
¥16.65+¥0.08 · +0.48%
Open 开盘
¥16.50
High 最高
¥17.04
Low 最低
¥16.45
Prev Close 昨收
¥16.57
Volume 成交量
598.3万股
Turnover 成交额
¥9,991.2万
Mkt Cap 总市值
¥96亿
P/E 市盈率
71.3×
Recent Activity 近期动态All Filings 全部公告 →
22 significant filings since 29 May 2026: 3 on court enforcement, 2 on regulatory inquiry and 9 on buyback, and 4 other kinds. The latest, on 27 Aug 2026: 圣湘生物科技股份有限公司关于实施回购股份注销暨股份变动公告.
自 29 May 2026 起有 22 份重大公告：court enforcement 3 份、regulatory inquiry 2 份、buyback 9 份，另有 4 类。最新一份（27 Aug 2026）：圣湘生物科技股份有限公司关于实施回购股份注销暨股份变动公告。
14.0014.5015.0015.5016.0016.5017.00
Volume 成交量
2,961.2万
25 Jun17 Jul10 Aug02 Sep24 Sep
Overview 概览Deep Report 深度报告Financials 财务Valuation 估值Ownership 股东Analysts 券商Estimates 预测News 动态Events 事件Peers 同业
Relative Value 同业比较
Medical Devices 医疗器械 · 140 listed peers
| Measure 指标 | This Company 本公司 | Peer Median 同业中值 | Standing 排位 | |
|---|---|---|---|---|
| Market Cap 市值 | ¥96亿 | ¥47亿 | 29th highest of 140 · 140 家中第 29 高 | |
| Trailing P/E 市盈率 | 71.3x | 40.4x | 29th highest of 101 · 101 家中第 29 高 | |
| P/B 市净率 | 1.4x | 2.4x | 23rd lowest of 140 · 140 家中第 23 低 | |
| Revenue Growth 营收增速 | -3.9% | 4.0% | 36th lowest of 140 · 140 家中第 36 低 | |
| Profit Growth 净利增速 | -39.8% | -2.6% | 33rd lowest of 140 · 140 家中第 33 低 | |
| Gross Margin 毛利率 | 71.3% | 55.2% | 19th highest of 140 · 140 家中第 19 高 | |
| Net Margin 净利率 | 9.7% | 10.7% | 66th lowest of 140 · 140 家中第 66 低 | |
| Return on Equity 净资产收益率 | 1.4% | 2.4% | 54th lowest of 140 · 140 家中第 54 低 | |
| Debt to Assets 资产负债率 | 26.6% | 19.2% | 50th highest of 140 · 140 家中第 50 高 | |
| Grade Score 评级得分 | 38 | 52 | 33rd lowest of 140 · 140 家中第 33 低 |
Statement figures are for the period to 30 Jun 2026, filed by 140 of 140 peers. A rank needs 5 or more peers with a value. A company with no earnings has no P/E. 报表数据为截至 30 Jun 2026 的期间，140 家同业中 140 家已披露。排位至少需要 5 家有数据的同业；无盈利的公司没有市盈率。
Largest Peers 主要同业
| Peer 同业 | Market Cap | P/E | P/B | Revenue Growth | Net Margin | ROE | Grade |
|---|---|---|---|---|---|---|---|
| Shenzhen Mindray Bio-Medical Electronics 迈瑞医疗 | ¥1,864亿 | 23.7x | 4.6x | 6.0% | 28.4% | 12.0% | C |
| Shanghai United Imaging Healthcare 联影医疗 | ¥844亿 | 47.7x | 3.8x | 17.2% | 12.6% | 4.1% | D |
| Shenzhen New Industries Biomedical 新产业 | ¥375亿 | 21.8x | 4.2x | 10.8% | 35.9% | 9.3% | B |
| APT Medical 惠泰医疗 | ¥334亿 | 35.8x | 10.8x | 25.7% | 34.6% | 16.0% | B |
| Wantai Biological 万泰生物 | ¥334亿 | — | 2.8x | 24.3% | -12.6% | -1.1% | D |
| Intco Medical Technology 英科医疗 | ¥322亿 | 28.3x | 1.7x | 40.6% | 13.1% | 4.5% | C |
| MGI Tech 华大智造 | ¥312亿 | — | 4.4x | 18.9% | -11.6% | -2.2% | D |
| Andon Health 九安医疗 | ¥288亿 | 6.5x | 1.2x | -30.6% | 578.7% | 13.7% | C |
| IRAY Group 奕瑞科技 | ¥279亿 | 38.7x | 3.6x | 56.7% | 25.0% | 6.4% | C |
| Jiangsu Yuyue Medical Equipment & Supply 鱼跃医疗 | ¥262亿 | 23.4x | 2.0x | -1.9% | 18.6% | 6.2% | C |
| Weigao Blood Purification 威高血净 | ¥216亿 | 44.0x | 1.8x | -0.4% | 13.1% | 3.2% | D |
| Lepu Medical Technology 乐普医疗 | ¥210亿 | 27.3x | 1.3x | -4.6% | 14.2% | 3.0% | D |
| Zhende Medical 振德医疗 | ¥207亿 | 74.8x | 3.6x | 5.9% | 6.8% | 2.5% | D |
| Autobio 安图生物 | ¥192亿 | 19.3x | 2.2x | -0.1% | 24.4% | 5.5% | C |
| Sansure Biotech 圣湘生物 | ¥96亿 | 71.3x | 1.4x | -3.9% | 9.7% | 1.4% | D |
Peers are listed by market cap, with this company highlighted. 同业按市值排列，本公司高亮显示。